S1PR1 and diabetic kidney disease: In the diabetic nephropathy mouse S1PR1 agonist, the renal tubular epithelial cell barrier and relaxation function are improved; meanwhile, the damaged epithelial cells are impaired, all of which improve kidney microcirculation [79].